In line with our observations, ALT levels were associated with an increased risk of CVD in a Dutch population after adjustment for determinants of the metabolic syndrome and other CV risk factors [37], and with c-IMT in Korean patients with different degrees of NAFLD [38]. The gene discussed is GPT; the disease is metabolic syndrome.